Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
225,970,109
-
Total 13F shares
-
207,752,105
-
Share change
-
-645,994
-
Total reported value
-
$97,963,233,994
-
Put/Call ratio
-
107%
-
Price per share
-
$471.56
-
Number of holders
-
1,648
-
Value change
-
-$247,874,299
-
Number of buys
-
723
-
Number of sells
-
681
Institutional Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q4 2023
As of 31 Dec 2023,
Elevance Health, Inc. - Common Stock (ELV) was held by
1,648 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
207,752,105 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, GEODE CAPITAL MANAGEMENT, LLC, Sanders Capital, LLC, FMR LLC, AMERIPRISE FINANCIAL INC, and Capital International Investors.
This page lists
1,649
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.